Inflammatory Cytokines in Association With High Fetal Hemoglobin Level Reduce the Episodes of Vaso-Occlusive Crisis in Sickle Cell Patients
- PMID: 40501516
- PMCID: PMC12151094
- DOI: 10.14740/jh1353
Inflammatory Cytokines in Association With High Fetal Hemoglobin Level Reduce the Episodes of Vaso-Occlusive Crisis in Sickle Cell Patients
Abstract
Background: Vaso-occlusive crisis (VOC), a common clinical manifestation of sickle cell disease (SCD), is mediated by a series of inflammatory responses. Conversely, a high fetal hemoglobin (Hb F) level is a known factor that reduces the severity of clinical presentations associated with SCD. Since the association between cytokine profiles and high Hb F levels in SCD is not well studied, this study aims to investigate the interaction between cytokines and Hb F levels in SCD patients from Odisha, India.
Methods: A total of 276 patients with SCD were recruited for the study, including 180 in steady state and 90 in crisis state. Additionally, 117 individuals with sickle cell trait (SCT) and 128 healthy controls were included for comparison.
Results: The study revealed that the total white blood cell count and interleukin (IL)-6 levels were significantly higher in crisis state SCD patients, while the red cell distribution width, IL-10, and Hb F level were significantly higher in steady state SCD patients. Most importantly, the logistic regression analysis showed that the interaction of Hb F with the cytokines IL-10, IL-1β, and IL-17 provided three times greater protection from crisis in SCD patients.
Conclusion: The significance of these preliminary findings has been discussed in terms of prognostic markers and supplements to increase the efficacy of hydroxyurea used to enhance Hb F production.
Keywords: Cytokine; Fetal hemoglobin; IL-6; Sickle cell disease; VOC.
Copyright 2025 Authors.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.Clin Vaccine Immunol. 2010 Apr;17(4):602-8. doi: 10.1128/CVI.00145-09. Epub 2010 Feb 3. Clin Vaccine Immunol. 2010. PMID: 20130127 Free PMC article.
-
Cytokine profile of sickle cell disease in Oman.Am J Hematol. 2004 Dec;77(4):323-8. doi: 10.1002/ajh.20196. Am J Hematol. 2004. PMID: 15551290
-
Pro-inflammatory cytokines associate with NETosis during sickle cell vaso-occlusive crises.Cytokine. 2020 Mar;127:154933. doi: 10.1016/j.cyto.2019.154933. Epub 2019 Nov 25. Cytokine. 2020. PMID: 31778959 Free PMC article.
-
Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.Cochrane Database Syst Rev. 2019 Nov 14;2019(11):CD012187. doi: 10.1002/14651858.CD012187.pub2. Cochrane Database Syst Rev. 2019. PMID: 31742673 Free PMC article.
-
The Neuropeptide Substance P is Elevated in Sickle Cell Disease and is a Marker of Severity of Vaso-occlusive Crisis.Niger Med J. 2024 Sep 26;65(4):398-402. doi: 10.60787/nmj-v65i3-419. eCollection 2024 Jul-Aug. Niger Med J. 2024. PMID: 39398396 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources